Is Januvia (sitagliptin) contraindicated with atenolol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No, Januvia (sitagliptin) is NOT contraindicated when taking atenolol

There are no documented contraindications or clinically significant drug interactions between sitagliptin and atenolol, and these medications can be safely used together. However, both medications require specific considerations in certain clinical contexts.

Evidence for Safety of Concomitant Use

  • Sitagliptin has been extensively studied in combination with various antihypertensive medications without evidence of contraindications with beta-blockers 1, 2, 3, 4
  • The drug has a low potential for pharmacokinetic drug-drug interactions, making it compatible with most cardiovascular medications 4
  • Clinical trials have demonstrated sitagliptin's safety profile when used alongside multiple medication classes, including antihypertensives 2, 3

Important Clinical Considerations

For Sitagliptin (Januvia)

Heart Failure Monitoring:

  • Use sitagliptin with caution in patients with a history of heart failure or renal impairment 5
  • Monitor for signs and symptoms of heart failure during therapy, and consider discontinuation if heart failure develops 5

Renal Dose Adjustments:

  • Standard dose: 100 mg daily for eGFR ≥45 mL/min/1.73 m² 5, 1
  • Moderate impairment: 50 mg daily 5
  • Severe impairment: 25 mg daily 5, 1

Hypoglycemia Risk:

  • Sitagliptin has a low intrinsic risk of hypoglycemia when used alone 2, 3, 4
  • Risk increases when combined with sulfonylureas or insulin, but not typically with beta-blockers alone 2, 3

For Atenolol

Specific Contraindications:

  • Pregnancy: Atenolol is specifically NOT recommended during pregnancy due to associations with fetal growth restriction and lower birth weight 6, 7
  • Other beta-blockers (like labetalol or metoprolol) are preferred alternatives in pregnant patients 6, 7

General Beta-Blocker Precautions:

  • Avoid in severe bronchospastic lung disease, decompensated heart failure, significant sinus or AV node dysfunction, and hypotension 6
  • Use caution in brittle diabetic patients with hypoglycemic events, as beta-blockers may mask hypoglycemia symptoms 6
  • May exacerbate depression; consider hydrophilic alternatives (atenolol or nadolol) if depression is a concern 6

Renal Dosing for Atenolol:

  • CrCl 15-35 mL/min: reduce to 50 mg/day 6
  • CrCl <15 mL/min: reduce to 25 mg/day 6

Common Pitfalls to Avoid

  • Do not confuse the lack of contraindication between these two drugs with the specific pregnancy contraindication for atenolol itself 6, 7
  • Do not assume all beta-blockers are equivalent—atenolol has specific limitations in pregnancy that other beta-blockers do not share 6, 7
  • Monitor renal function regularly when using both medications, as both require dose adjustments in renal impairment 6, 5, 1
  • Be vigilant for heart failure symptoms when using sitagliptin, particularly in patients already on beta-blockers for cardiac conditions 5

References

Guideline

Contraindications and Precautions for Sitagliptin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hypertension in Diabetic Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.